Oh, E Y <br/><br/>
Pharmacokinetic and pharmacodynamic consequences of inhibition of terazosin metabolism via CYP3A1 and/or 3A2 by DA-8159, an erectogenic, in rats.  [electronic resource] 

 -  British journal of pharmacology  May 2007 
 - 24-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1188 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjp.0707192  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aryl Hydrocarbon Hydroxylases--physiology<br/>Cytochrome P-450 CYP3A<br/>Dexamethasone--pharmacology<br/>Drug Interactions<br/>Male<br/>Membrane Proteins--physiology<br/>Microsomes, Liver--metabolism<br/>Prazosin--administration & dosage<br/>Pyrimidines--pharmacokinetics<br/>Rats<br/>Rats, Sprague-Dawley<br/>Sulfonamides<br/>Troleandomycin--pharmacology